By Christy Santhosh (Reuters) -Regeneron Pharmaceuticals beat Wall Street estimates for third-quarter results on Tuesday, helped by strong demand for its eczema treatment, Dupixent, and cancer treatment Libtayo, sending shares...
Emirates NBD, Dubai’s largest banking group, has announced an open offer to acquire up to 26% of RBL Bank at Rs 280 per share, valuing the deal at Rs 11,636 crore. The open offer, made...
NEW DELHI: Anil Agarwal-led Vedanta Resources, as part of its deleveraging exercise, has proposed to repay $920-million debt in the current fiscal year...
Moody's Ratings on Wednesday said it has upgraded the corporate family rating of Vedanta Resources Ltd (VRL) following its successful liability management exercises....